
                <!DOCTYPE html>
                <html lang="en">
                <head>
                    <meta charset="UTF-8">
                    <meta name="viewport" content="width=device-width, initial-scale=1.0">
                    <title>$6 million grant drives potential treatment for common cause of vision loss - HSC News</title>
                </head>
                <body>
                    <h1>$6 million grant drives potential treatment for common cause of vision loss - HSC News</h1>
                    <h2>Headings:</h2>
                    
                    <h2>Paragraphs:</h2>
                    <p>The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing a therapy for dry age-related macular degeneration.    (Photo/Adobe Stock)</p><p>TheCalifornia Institute for Regenerative Medicine(CIRM), the stateâ€™s stem cell agency, has awarded a two-year, $6 million grant to a team at theUSC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeuticsand theUSC Roski Eye Instituteadvancing a new treatment for one of the leading causes of blindness in older adults. The funding will enable the researchers to conduct preclinical studies needed before launching human trials.</p><p>The investigators aim to accelerate progress in fighting dry age-related macular degeneration (AMD), which affects about 16 million people in the U.S. Dry AMD, which typically manifests in people 50 and older, is currently incurable and can eventually render those suffering legally blind.</p><p>Treatment options are presently limited to well-established vitamin supplements and newly emerged immune-regulating treatments, both of which can only slow the progression of dry AMD.</p><p>To read more,click here.</p>
                </body>
                </html>
            